Skip to main content
. 2022 Dec 2;12:1056572. doi: 10.3389/fonc.2022.1056572

Table 3.

Information on lung cancer samples in the test set.

Project name Subproject Number/percentage
Lung cancer Adenocarcinoma 89 (54.6%)
Squamous carcinoma 51 (31.3%)
Other cancers 23 (14.1%)
Stage Stage I 67 (41.1%)
Stage II 96 (58.9%)
Gender Male 69 (42.3%)
Female 94 (57.7%)